REGULATED PRESS RELEASE published on 10/30/2023 at 06:00, 2 years 6 months ago Biophytis et Innovation Solutions Pharma signent un partenariat en vue d’accélérer l’accès au marché de Sarconeos (BIO101) au Brésil
PRESS RELEASE published on 10/27/2023 at 23:00, 2 years 6 months ago Biophytis receives notice of delisting from Nasdaq and announces it will request a hearing before the Nasdaq Hearings Panel
PRESS RELEASE published on 10/27/2023 at 23:00, 2 years 6 months ago Biophytis reçoit un avis de radiation du Nasdaq et annonce qu’elle fera appel de cette décision auprès du Comité d’Audience du Nasdaq
REGULATED PRESS RELEASE published on 10/27/2023 at 23:00, 2 years 6 months ago Biophytis reçoit un avis de radiation du Nasdaq et annonce qu’elle fera appel de cette décision auprès du Comité d’Audience du Nasdaq
REGULATED PRESS RELEASE published on 10/27/2023 at 23:00, 2 years 6 months ago Biophytis receives notice of delisting from Nasdaq and announces it will request a hearing before the Nasdaq Hearings Panel
REGULATED PRESS RELEASE published on 10/23/2023 at 07:00, 2 years 6 months ago Biophytis announces the launch of a rights issue with maintenance of shareholders’ preferential subscription rights to continue the execution of its strategic roadmap
REGULATED PRESS RELEASE published on 10/23/2023 at 07:00, 2 years 6 months ago Biophytis annonce le lancement d’une augmentation de capital sous forme d’émission d’ABSAR avec maintien du droit préférentiel de souscription des actionnaires afin de poursuivre l’exécution de sa feuille de route stratégique
PRESS RELEASE published on 09/27/2023 at 23:15, 2 years 7 months ago Biophytis publie ses comptes semestriels au 30 juin 2023 et fait le point sur ses activités
PRESS RELEASE published on 09/27/2023 at 23:15, 2 years 7 months ago Biophytis releases its half-yearly accounts as of 30 June 2023 and provides an update on its operations
PRESS RELEASE published on 09/25/2023 at 07:06, 2 years 7 months ago Biophytis et Skyepharma signent un partenariat pour la production de Sarconeos (BIO101)
Published on 05/08/2026 at 15:55, 3 hours 27 minutes ago Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 4 hours 22 minutes ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 4 hours 27 minutes ago Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 4 hours 52 minutes ago Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 5 hours 22 minutes ago BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program
Published on 05/08/2026 at 19:12, 9 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 19 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
